Literature DB >> 11592767

HPV types and cofactors causing cervical cancer in Peru.

C Santos1, N Muñoz, S Klug, M Almonte, I Guerrero, M Alvarez, C Velarde, O Galdos, M Castillo, J Walboomers, C Meijer, E Caceres.   

Abstract

We conducted a hospital-based case-control study in Peru of 198 women with histologically confirmed cervical cancer (173 squamous cell carcinomas and 25 cases of adenocarcinoma/adenosquamous carcinoma) and 196 control women. Information on risk factors was obtained by personal interview. Using PCR-based assays on exfoliated cervical cells and biopsy specimens, HPV DNA was detected in 95.3% of women with squamous cell carcinoma and in 92.0% of women with adenocarcinoma/adenosquamous carcinoma compared with 17.7% in control women. The age-adjusted odds ratio was 116.0 (95% Cl = 48.6-276.0) for squamous cell carcinoma and 51.4 (95% Cl = 11.4-232.0) for adenocarcinoma/adenosquamous carcinoma. The commonest types in women with cervical cancer were HPV 16, 18, 31, 52 and 35. The association with the various HPV types was equally strong for the two most common types (HPV 16 and 18) as for the other less common types. In addition to HPV, long-term use of oral contraceptives and smoking were associated with an increased risk. HPV is the main cause of both squamous cell carcinoma and adenocarcinoma in Peruvian women. Copyright 2001 Cancer Research Campaign

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592767      PMCID: PMC2375092          DOI: 10.1054/bjoc.2001.1948

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

2.  Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.

Authors:  J V Lacey; L A Brinton; F M Abbas; W A Barnes; P E Gravitt; M D Greenberg; S M Greene; O C Hadjimichael; L McGowan; R Mortel; P E Schwartz; S G Silverberg; A Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

3.  CLUSTAL: a package for performing multiple sequence alignment on a microcomputer.

Authors:  D G Higgins; P M Sharp
Journal:  Gene       Date:  1988-12-15       Impact factor: 3.688

4.  Human papillomavirus infection and invasive cervical cancer in Paraguay.

Authors:  P A Rolón; J S Smith; N Muñoz; S J Klug; R Herrero; X Bosch; F Llamosas; C J Meijer; J M Walboomers
Journal:  Int J Cancer       Date:  2000-02-15       Impact factor: 7.396

5.  The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain.

Authors:  N Muñoz; F X Bosch; S de Sanjosé; L Tafur; I Izarzugaza; M Gili; P Viladiu; C Navarro; C Martos; N Ascunce
Journal:  Int J Cancer       Date:  1992-11-11       Impact factor: 7.396

6.  Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions.

Authors:  R Mittal; A Pater; M M Pater
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia.

Authors:  F X Bosch; N Muñoz; S de Sanjosé; C Navarro; P Moreo; N Ascunce; L C Gonzalez; L Tafur; M Gili; I Larrañaga
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1993 Sep-Oct       Impact factor: 4.254

8.  Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia.

Authors:  N Muñoz; F X Bosch; S de Sanjosé; A Vergara; A del Moral; M T Muñoz; L Tafur; M Gili; I Izarzugaza; P Viladiu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1993 Sep-Oct       Impact factor: 4.254

9.  Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort.

Authors:  J M Deacon; C D Evans; R Yule; M Desai; W Binns; C Taylor; J Peto
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  Human papillomavirus and invasive cervical cancer in Brazil.

Authors:  J Eluf-Neto; M Booth; N Muñoz; F X Bosch; C J Meijer; J M Walboomers
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

View more
  17 in total

Review 1.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

2.  Human papillomavirus infection in female sex workers in Lima, Peru.

Authors:  Silvia M Montano; Evelyn J Hsieh; Martha Calderón; Thanh G N Ton; Eberth Quijano; Vicky Solari; Joseph R Zunt
Journal:  Sex Transm Infect       Date:  2010-09-02       Impact factor: 3.519

3.  Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia.

Authors:  M Molano; E Weiderpass; H Posso; S A Morré; M Ronderos; S Franceschi; A Arslan; C J L M Meijer; N Muñoz; A J C van den Brule
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

Review 4.  Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis.

Authors:  Agustín Ciapponi; Ariel Bardach; Demián Glujovsky; Luz Gibbons; María Alejandra Picconi
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

5.  Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy.

Authors:  Maria Lina Tornesello; Maria Luisa Duraturo; Luigi Buonaguro; Gabriele Vallefuoco; Roberto Piccoli; Stefano Palmieri; Franco M Buonaguro
Journal:  Infect Agent Cancer       Date:  2007-01-03       Impact factor: 2.965

6.  Detection of human papillomavirus in chronic cervicitis, cervical adenocarcinoma, intraepithelial neoplasia and squamus cell carcinoma.

Authors:  Elahe Mirzaie-Kashani; Majid Bouzari; Ardeshir Talebi; Farahnaz Arbabzadeh-Zavareh
Journal:  Jundishapur J Microbiol       Date:  2014-05-01       Impact factor: 0.747

7.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

8.  HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country.

Authors:  Raúl Murillo; Mónica Molano; Gilberto Martínez; Juan-Carlos Mejía; Oscar Gamboa
Journal:  Infect Dis Obstet Gynecol       Date:  2009-12-20

9.  Human Papillomavirus type distribution in invasive cervical cancer in Uganda.

Authors:  Michael Odida; Silvia de Sanjosé; Wim Quint; Xavier F Bosch; Joellen Klaustermeier; Elisabete Weiderpass
Journal:  BMC Infect Dis       Date:  2008-06-24       Impact factor: 3.090

10.  Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer.

Authors:  J Green; A Berrington de Gonzalez; S Sweetland; V Beral; C Chilvers; B Crossley; J Deacon; C Hermon; P Jha; D Mant; J Peto; M Pike; M P Vessey
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.